Bristol-Myers Squibb is widely recognised for excellence in providing some of the world's most important medicines for patients. At the same time, we strive to be transparent by providing information about treatments we are studying, whether they are investigational compounds, or new indications for existing marketed products.

At Bristol-Myers Squibb we work in partnership with many organisations and individuals to meet the needs of patients. Bristol-Myers Squibb is committed to working in partnership with others in a way which is fully compliant with the Medicines Australia's Code of Conduct. Our objective is to act ethically and transparently with our stakeholders and the wider community. Information on the transparency requirements under the Medicines Australia Code of Conduct can be found in the links below or on the Medicines Australia Website.

Please use the links below for further information:


Collection Statement – Healthcare Professional Engagement

Disclosure Reports

Bristol-Myers Squibb has prepared the report for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and Australia’s Privacy legislation.  The report identifies healthcare professionals by name where their consent has been provided.  Where consent has not been provided the information is reported in aggregate.


From 1 October 2016, reporting these payments will be mandatory – details will be reported because healthcare professionals should reasonably expect that all Reportable Payments will be disclosed for each healthcare professional, by name.

The report is designed to be read on this website.  It is also provided as a downloadable CSV file. 


To comply with our privacy obligations, the report may be amended from time to time.  The report here contains the most up to date information.  Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988.


  • You may search the pdf by physician name or entity name (by using the CTRL F function), which is presented alphabetically by first name and last name or institution name. You can also click on the
  • The data in the report issued on 31 August 2016, covers the period from 1 October 2015 to 30 April 2016. Click on the links below to open.

 Reporting Period

Searchable PDF

 CSV Excel File

01 May 2016 - 31 October 2016



 01 October 2015 - 30 April 2016




Frequently Asked Questions

What is the Medicines Australia Code of Conduct (the Code)?

In May 2015, Medicines Australia implemented a revised Code of Conduct requiring its member companies to track and publish payments and transfers of value to Healthcare Professionals, in addition to the existing report for health consumer organisations. The purpose of disclosure of payments is to demonstrate industry transparency and help the general public to understand the collaborative nature and extent of programs intended to increase the quality use of medicines.

  • The reporting cycle is a six monthly cycle.
  • The report must be published within 4 months following the end of each reporting period.
  • Companies must publish the data about payments and transfers of value on companies' own websites.

What are the specifics of the Code?

The Code of Conduct requires Medicines Australia Member Companies, including BMS, to provide three types of reports:

  • Educational Event Reports – covers all educational meetings and symposia held or sponsored by a member company; these are reported every six months.
  • Healthcare Professional Transparency Report – covers all transfers of value associated with honoraria, airfares, accommodation and registration provided to healthcare professionals.
  • Health Consumer Organisation Support Reports – reports on the nature of companies' relationships with health consumer organisations including the monetary value of any financial support; this is an annual report for each calendar year.

What is the definition of healthcare professional in the context of the Medicines Australia Code?

Under the provisions of the Code of Conduct, a healthcare professional is a member of a medical, dental, pharmacy or nursing profession and any other person who in the course of their professional activities may prescribe, supply or administer a prescription medicine.

What is reported under the Healthcare Consumer Organisation report?

Each Member Company must provide to Medicines Australia for publication on its website, a report listing Health Consumer Organisations to which it provides financial support and/or significant direct/indirect non-financial support. The published report must include:

  • The name of the Health Consumer Organisation.
  • A description of the nature of the support that is sufficiently complete to enable the average reader to form an understanding of the nature of the support.
  • The monetary value of financial support or for significant non-financial support that cannot be assigned a meaningful monetary value, the published information must describe clearly the non-monetary value that the organisation receives.

What information about healthcare professionals will be reported and published?

  • Date of the event or provision of service.
  • Healthcare professional's name.
  • Type of healthcare professional (i.e. medical practitioner, pharmacist, nurse practitioner).
  • Healthcare professional's principal practice address.
  • Description of the service (i.e. speaker, Advisory Board member, Chairperson at educational meeting etc).
  • Description of the event (i.e. company sponsored meeting in Australia; independent meeting held in Australia; independent meeting held overseas; etc).
  • Whether the payment was made to the healthcare professional or a third party.
  • The amount of the payment or transfer of value, subdivided into (where relevant) registration fees, airfares and accommodation, and fees for service.

What activities are reported by companies for individual healthcare professionals?

  • Consulting fees and/or speaking fees.
  • Sponsorship of a healthcare professional to attend an educational event: airfares, accommodation and/or registration fees (whether held within or outside Australia).
  • Fees paid to healthcare professional consultants in Australia, or to their employers on their behalf, for specific services rendered by them: consulting fees, accommodation and airfares (whether within or outside Australia).
  • Fees paid to healthcare professionals in their role as Advisory Board members: sitting fees, accommodation and airfares (whether within or outside Australia).
  • Fees paid to healthcare professionals for the purpose of market research ONLY where the identity of the healthcare professional is known to the company.
  • Payment of an educational grant or sponsorship to a specific healthcare professional.

What Transfers of Value are excluded from Disclosure?

The following are not transfers of value for the purposes of the Code (list not exhaustive):

  • Hospitality (food and beverages
  • Airport ground transfers, taxis, parking fees.
  • Venue costs (e.g. room and/or audio-visual equipment hire).

Australia Code of Conduct

If you have a question about transactions reported by Bristol-Myers Squibb, email your inquiries to: